NCT00408252 2019-09-19
Efficacy of SU 011248 in Head And Neck Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 2 Terminated
Clinical Trials
4 trialsNCT02623127 2019-01-23
KOSMIC
Seoul National University Hospital
Phase 2 Completed
NCT00535379 2010-08-30
SURGE01-07
Medical University Innsbruck
Phase 2 Unknown
NCT00371553 2009-07-08
Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
British Columbia Cancer Agency
Phase 2 Completed